# MAXCYTE, INC. (MXCT) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from MAXCYTE, INC.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/MXCT/mda/fy2025/): filed 2026-03-25; accession 0001104659-26-034557 (https://www.sec.gov/Archives/edgar/data/1287098/000110465926034557/mxct-20251231x10k.htm); latest 10-K
- [FY 2024 MD&A](/company/MXCT/mda/fy2024/): filed 2025-03-11; accession 0001558370-25-002721 (https://www.sec.gov/Archives/edgar/data/1287098/000155837025002721/mxct-20241231x10k.htm)
- [FY 2023 MD&A](/company/MXCT/mda/fy2023/): filed 2024-03-12; accession 0001558370-24-003001 (https://www.sec.gov/Archives/edgar/data/1287098/000155837024003001/mxct-20231231x10k.htm)
- [FY 2022 MD&A](/company/MXCT/mda/fy2022/): filed 2023-03-15; accession 0001558370-23-003911 (https://www.sec.gov/Archives/edgar/data/1287098/000155837023003911/mxct-20221231x10k.htm)
- [FY 2021 MD&A](/company/MXCT/mda/fy2021/): filed 2022-03-22; accession 0001558370-22-004081 (https://www.sec.gov/Archives/edgar/data/1287098/000155837022004081/mxct-20211231x10k.htm)

Back to /company/MXCT/